SCINAI IMMUNOTHERAPEUTICS

Serial Number 79387398
Registration 7561660
700

Registration Progress

Application Filed
Aug 22, 2023
Under Examination
Approved for Publication
Aug 27, 2024
Published for Opposition
Aug 27, 2024
Registered
Nov 12, 2024

Trademark Image

SCINAI IMMUNOTHERAPEUTICS

Basic Information

Serial Number
79387398
Registration Number
7561660
Filing Date
August 22, 2023
Registration Date
November 12, 2024
Published for Opposition
August 27, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 12, 2024
Registration
Registered
Classes
005

Rights Holder

Scinai Immunotherapeutics Ltd.

03
Address
Jerusalem BioPark Building, 2nd Floor,
Hadassah Ein Kerem Campus Jerusalem
IL

Ownership History

BiondVax Pharmaceuticals Ltd.

Original Applicant
03
IL

Scinai Immunotherapeutics Ltd.

New Owner Before Publication #1
03
IL

Scinai Immunotherapeutics Ltd.

Owner at Publication
03
IL

Scinai Immunotherapeutics Ltd.

Original Registrant
03
IL

Legal Representation

Attorney
Kevin D. McCarthy

USPTO Deadlines

Next Deadline
1937 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-11-12)
Due Date
November 12, 2030
Grace Period Ends
May 12, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

30 events
Date Code Type Description Documents
Jun 27, 2025 OPNX P NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Loading...
Jun 10, 2025 OPNR P NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Loading...
Jun 10, 2025 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
May 3, 2025 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Apr 13, 2025 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Apr 13, 2025 FIMP P FINAL DISPOSITION PROCESSED Loading...
Feb 12, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Nov 12, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 12, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 27, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 27, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 7, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 23, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 23, 2024 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jul 18, 2024 ADCH M CHANGE OF NAME/ADDRESS REC'D FROM IB Loading...
Jul 9, 2024 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jul 9, 2024 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jul 9, 2024 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Jul 8, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 8, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 8, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 22, 2024 RFNT P REFUSAL PROCESSED BY IB Loading...
May 1, 2024 RFRR P REFUSAL PROCESSED BY MPU Loading...
May 1, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Apr 24, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Apr 23, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 23, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 16, 2024 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jan 12, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 11, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations comprising antigen-binding polypeptides for prevention and treatment of infectious diseases, immune and inflammatory diseases, malignancies and cancers, metabolic diseases, cardiovascular diseases, diseases of the central nervous system, and neurodegenerative diseases; Pharmaceutical preparations comprising immunoglobulin moieties, fragments or derivatives thereof for prevention and treatment of infectious diseases, immune and inflammatory diseases, malignancies and cancers, metabolic diseases, cardiovascular diseases, diseases of the central nervous system, and neurodegenerative diseases

Additional Information

Pseudo Mark
SCINAI IMMUNO THERAPEUTICS

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"IMMUNOTHERAPEUTICS"